Results 231 to 240 of about 413,694 (387)

Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Vaccine adjuvants are essential for enhancing immune responses to vaccines, particularly in immunocompromised populations who typically demonstrate suboptimal responses to standard vaccination. This narrative review evaluates the safety and efficacy of approved and candidate adjuvants in immunocompromised hosts, with emphasis on solid organ ...
Haya Hayek   +8 more
wiley   +1 more source

Acute liver disorders in the third trimester—AFLP, HELLP and infectious hepatitis—update on pathology, diagnosis and management

open access: yesThe Obstetrician &Gynaecologist, EarlyView.
Key content The epidemiology and pathophysiology of AFLP, HELLP syndrome and infectious viral hepatitis in late pregnancy. Clinical presentation, diagnosis and management of these conditions. Complications (maternal and fetal) and how these can be managed. The role of a multidisciplinary team in management.
Victor N. Chilaka   +4 more
wiley   +1 more source

FRI0248 Myasthenia gravis after hepatitis b vaccine. report of one case [PDF]

open access: bronze, 2001
ME Bahri   +4 more
openalex   +1 more source

FIGO guideline on liver disease and pregnancy

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 170, Issue 1, Page 28-48, July 2025.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy